Editas Medicine (STU:8EM) Other Long Term Assets : €8.73 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Editas Medicine Other Long Term Assets?

Editas Medicine's other long-term assets for the quarter that ended in Mar. 2024 was €8.73 Mil.

Editas Medicine's quarterly other long-term assets increased from Sep. 2023 (€5.39 Mil) to Dec. 2023 (€7.87 Mil) and increased from Dec. 2023 (€7.87 Mil) to Mar. 2024 (€8.73 Mil).

Editas Medicine's annual other long-term assets declined from Dec. 2021 (€6.03 Mil) to Dec. 2022 (€4.96 Mil) but then increased from Dec. 2022 (€4.96 Mil) to Dec. 2023 (€7.87 Mil).

Editas Medicine Other Long Term Assets Historical Data

The historical data trend for Editas Medicine's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Editas Medicine Other Long Term Assets Chart

Editas Medicine Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

4.85

3.86

6.03

4.96

7.87

Editas Medicine Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long Term Assets	Get a 7-Day Free Trial															6.31	4.85	5.39	7.87	8.73

Editas Medicine Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Editas Medicine (STU:8EM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Editas Medicine Inc (STU:8EM) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

EDIT:USA 0IFK:UK 8EM:Germany

Address

11 Hurley Street, Cambridge, MA, USA, 02141

Website

https://www.editasmedicine.com

Editas Medicine Inc is a genome editing company. It is engaged in treating patients with genetically defined diseases by correcting disease-causing genes. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.

Editas Medicine (STU:8EM) Headlines

No Headlines